Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN115 adjunctive therapy in levodopa-treated Parkinson's disease with end-of-dose wearing off
2011-005054-59Phase 2Completed
- Sponsor
- Biotie Therapies
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing tozadenant + levodopa with placebo + levodopa (2 arms). Started Jun 2013; status: completed.
02
Drugs
tozadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2011-005054-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005054-59.